391
Caribou Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
260
FY23:
339
FY24:
219
FY25:
145
(positive)
Change from FY21 to FY25
millions USD
FY21:
51.2
FY22:
114
FY23:
93.4
FY24:
93.9
FY25:
30.1
Total assets
Change from FY21 to FY25
millions USD
FY21:
442
FY22:
374
FY23:
432
FY24:
313
FY25:
175
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
25.8
FY22:
28.1
FY23:
28.3
FY24:
30.7
FY25:
25.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
28.7
FY22:
44.8
FY23:
35.5
FY24:
29.7
FY25:
27.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
388
FY22:
301
FY23:
368
FY24:
253
FY25:
122
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
442
FY22:
374
FY23:
432
FY24:
313
FY25:
175
All amounts in millions USD